title: Engagement of the CD4 receptor inhibits the interleukin-2-dependent proliferation of human T cells transformed by Herpesvirus saimiri.
abstract: Infection with Herpesvirus saimiri, a tumor virus of non-human primates, transformed human CD4+ T cell clones to permanent interleukin (IL)-2-dependent growth without need for restimulation with antigen and accessory cells. The IL-2-dependent proliferation of these cells was dramatically inhibited by soluble anti-CD4 whole antibodies, F(ab')2 and Fab fragments, and also by gp 120 of human immunodeficiency virus. The inhibition was not due to cell death and could be overcome by high concentrations of exogenous IL-2. Cell surface expression of CD4, and to a lesser degree the density of the IL-2 receptor alpha chain, were reduced upon anti-CD4 treatment. After long lasting (> 12 h) incubation with anti-CD4, abundance and activity of CD4-bound p56lck were diminished while the free fraction of p56lck remained unchanged. Since IL-2 binding to its receptor activated only the CD4-bound fraction of p56lck, the IL-2-induced p56lck activity was diminished after long-term CD4 ligation. Taken together, our results suggest a cross talk between CD4- and IL-2 receptor-mediated signaling via p56lck.
authors.affiliation: Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton.
authors.forename: B M
authors.initials: BM
authors.lastname: Bröker
authors.forename: A Y
authors.initials: AY
authors.lastname: Tsygankov
authors.forename: H
authors.initials: H
authors.lastname: Fickenscher
authors.forename: N A
authors.initials: NA
authors.lastname: Chitaev
authors.forename: I
authors.initials: I
authors.lastname: Müller-Fleckenstein
authors.forename: B
authors.initials: B
authors.lastname: Fleckenstein
authors.forename: J B
authors.initials: JB
authors.lastname: Bolen
authors.forename: F
authors.initials: F
authors.lastname: Emmrich
authors.forename: H
authors.initials: H
authors.lastname: Schulze-Koops
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D017209:Apoptosis; D015704:CD4 Antigens / Q000502:physiology*; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D015699:HIV Envelope Protein gp120 / Q000494:pharmacology; D006567:Herpesvirus 2, Saimiriine / Q000235:genetics*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D008213:Lymphocyte Activation; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck); D011518:Proto-Oncogene Proteins / Q000502:physiology; D015375:Receptors, Interleukin-2 / Q000032:analysis; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D007376:Interleukin-2; D011518:Proto-Oncogene Proteins; D015375:Receptors, Interleukin-2; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck)